Product development resource
Tablet Packaging and Stability: Bottles, Blisters and Barrier Decisions
Tablet packaging must protect chemical, physical and mechanical performance through storage, transport and consumer use. Barrier selection follows the product's evidence.
Short answer
Tablet packaging should preserve the attributes established during formulation and manufacturing: identity, potency, physical integrity, disintegration or dissolution, appearance and microbiological suitability where relevant.
Bottle versus blister is not a universal quality ranking. The result depends on the formulation, coating, barrier materials, closure or seal, pack count, opening pattern, distribution and shelf-life evidence.
Evidence guide: Published evidence — supported by the linked technical source. · Development guidance — a practical decision or testing framework, not a universal specification. · Manufacturer-specific — depends on the selected site, equipment and commercial arrangement. · Product-specific validation — must be demonstrated with the actual formula, process, pack and market.
Define what can change
Moisture can soften, harden or chemically affect a tablet and alter disintegration. Oxygen or light may degrade susceptible ingredients. Vibration and impact can cause chipping or abrasion. Odours or volatile interactions can affect sensory products. Coatings can crack, pick up moisture or change appearance.
The tablet formulation and compression history determine part of this sensitivity; packaging cannot compensate for an intrinsically unstable core.
Bottle versus blister
| Decision | Bottle | Blister |
|---|---|---|
| Dose exposure | Remaining tablets are exposed when opened | Unopened units remain individually sealed |
| Pack efficiency | Efficient for larger counts | More area and material per unit |
| Barrier | Depends on bottle, closure, liner, seal and desiccant | Depends on formed web, lidding and seals |
| Mechanical separation | Units share the container | Units are separated in cavities |
| Consumer use | Familiar, resealable | Unit tracking and portability may improve |
Cold-form and thermoformed blisters are not equivalent. Specify the actual structure and demonstrated barrier.
Desiccant and headspace
Bottle headspace, residual moisture, closure ingress and opening frequency affect desiccant demand. Select type and capacity against the complete system and intended use. Do not assume a sachet automatically protects every tablet or that more drying is always beneficial.
For effervescent products, moisture risk is materially different; use the dedicated effervescent moisture and packaging guide.
Mechanical and coating protection
Tablet hardness and friability influence what survives filling, transport and consumer handling. Coated tablets also need room and surface protection that avoid abrasion, sticking or visual damage. Packaging line drops, counting systems and high-speed transfer can expose weaknesses missed in a static laboratory sample.
Stability and in-use evidence
Use final or justified representative packs in stability work. Include chemical, physical and performance attributes relevant to the formula, plus package integrity. If a bottle is repeatedly opened over 30, 60 or 90 days, consider whether an in-use assessment is needed to represent that exposure.
Shelf life belongs to the formula-process-package system. It should not be copied from another tablet sharing only the same format.
Packaging brief
Document tablet dimensions, count, coating, sensitivities, target markets, distribution, shelf life, bottle or blister preference, accessibility requirements and artwork status. Ask the manufacturer which structures are available, which are stocked, component and print MOQs, tooling needs, integrity controls and stability support.
Sources and evidence boundaries
- Partheniadis, Terzi and Nikolakakis, “Finite Element Analysis and Modeling in Pharmaceutical Tableting,” Pharmaceutics 14 (2022): 673. Full text
- Jakubowska and Ciepluch, “Blend Segregation in Tablets Manufacturing and Its Effect on Drug Content Uniformity—A Review,” Pharmaceutics 13 (2021): 1909. Full text
- Markl and Zeitler, “A Review of Disintegration Mechanisms and Measurement Techniques,” Pharmaceutical Research 34 (2017): 890–917. Full text
- ICH, “Q1A(R2): Stability Testing of New Drug Substances and Products.” Official guideline
ICH stability principles support studying environmental effects and the proposed container closure. Package choice and shelf life still require product-specific evidence.